15249-21 SPINAL 22G/25G QUINCKE- anesthesia conduction kit

Kraj: Stany Zjednoczone

Język: angielski

Źródło: NLM (National Library of Medicine)

Składnik aktywny:

EPINEPHRINE (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH)

Dostępny od:

Smiths Medical ASD, Inc.

INN (International Nazwa):

EPINEPHRINE

Skład:

EPINEPHRINE 1 mg in 1 mL

Wskazania:

Epinephrine is used to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of anesthetics. Its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine Injection can be utilized to prolong the action of anesthetics used in local and regional anesthesia. Epinephrine is co

Podsumowanie produktu:

Unit of Sale Total Strength/ Total Volume (Concentration) Each NDC 0409-7241-61  Case of 800 1 mg/mL NDC 0409-7241-60 1 mL single dose Ampule Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from light. Revised: 11/2015                                                                                  EN-4114                                                                    Hospira, Inc., Lake Forest, IL 60045 USA           Lidocaine Hydrochloride Injection, USP is supplied as follows: Unit of Sale Concentration Each Single-dose NDC 0409-4278-01 Tray of 25 0.5% 250 mg/50 mL (5 mg/mL) NDC 0409-4278-16 Glass Teartop Vial NDC 0409-4713-02 Carton of 25 1% 50 mg/5 mL (10 mg/mL) NDC 0409-4713-12 Glass Ampul NDC 0409-4713-32 Carton of 50 1% 20 mg/2 mL (10 mg/mL) NDC 0409-4713-42 Glass Ampul NDC 0409-4713-62 Case of 800 1% 20 mg/2 mL (10 mg/mL) NDC 0409-4713-72 Glass Ampul NDC 0409-4713-65 Case of 800 1% 50 mg/5 mL (10 mg/mL) NDC 0409-4713-75 Glass Ampul NDC 0409-4279-02 Carton of 25 1% 300 mg/30 mL (10 mg/mL) NDC 0409-4279-16 Glass Teartop Vial NDC 0409-4270-01 Case of 25 1% 300 mg/30 mL (10 mg/mL) NDC 0409-4270-11 Sterile Glass Teartop Vial NDC 0409-4776-01 Carton of 25 1.5% 300 mg/20 mL (15 mg/mL) NDC 0409-4776-10 Glass Ampul NDC 0409-4056-01 Carton of 5 1.5% 300 mg/20 mL (15 mg/mL) NDC 0409-4056-11 Sterile Glass Ampul NDC 0409-4282-01 Bundle of 25 2% 40 mg/2 mL (20mg/mL) NDC 0409-4282-11 Glass Ampul NDC 0409-4282-02 Carton of 25 2% 200 mg/10 mL (20 mg/mL) NDC 0409-4282-12 Glass Ampul Unit of Sale Concentration Each Multiple-dose: NDC 0409-4275-01 Tray of 25 0.5% 250 mg/50 mL (5 mg/mL) NDC 0409-4275-16 Plastic Fliptop Vial NDC 0409-4276-01 Tray of 25 1% 200 mg/20 mL (10 mg/mL) NDC 0409-4276-16 Plastic Fliptop Vial NDC 0409-4276-02 Tray of 25 1% 500 mg/50 mL (10 mg/mL) NDC 0409-4276-17 Plastic Fliptop Vial NDC 0409-4277-01 Tray of 25 2% 400 mg/20 mL (20 mg/mL) NDC 0409-4277-16 Plastic Fliptop bottle NDC 0409-4277-02 Tray of 25 2% 1000 mg/50 mL (20 mg/mL) NDC 0409-4277-17 Plastic Fliptop Vial Single-dose products are preservative-free. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Lidocaine Hydrochloride Injection, USP solutions packaged in ampuls and glass teartop vials may be autoclaved one time only. Autoclave at 15 pounds pressure, 121°C (250°F) for 15 minutes. DO NOT AUTOCLAVE PRODUCT IN PLASTIC VIALS. Revised: 1/2015                                                                               EN-3679 Hospira, Inc., Lake Forest, IL 60045 USA    5% Lidocaine Hydrochloride and 7.5% Dextrose Injection, USP, is supplied in the following: Unit of Sale Clamcell Each NDC 0409-4712-01 Bundle of 25 NDC 0409-4712-11 5 Pack NDC 0409-4712-11 2 mL Single-dose Ampul Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] 1. Lambert DH and Hurley RJ: Cauda Equina syndrome and continuous spinal anesthesia. Anesth and Analg 72:817-9, 1991. 2. Ready, LB, et al: Neurotoxicity of local anesthetics in rabbits. Anesthesiology 63:364-70, 1985. Revised: 10/2015                                                                               EN-4044 Hospira, Inc., Lake Forest, IL 60045 USA                                        Bupivacaine Spinal (Bupivacaine in Dextrose Injection, USP) is supplied in 2 mL ampuls (15 mg bupivacaine hydrochloride with 165 mg dextrose anhydrous) packaged in cartons of 10 (NDC No. 0409-3613-01). Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Revised: 6/2015 EN-3967 Hospira, Inc., Lake Forest, IL 60045 USA

Status autoryzacji:

Premarket Notification

Charakterystyka produktu

15249-21 SPINAL 22G/25G QUINCKE- ANESTHESIA CONDUCTION KIT
SMITHS MEDICAL ASD, INC.
----------
EPINEPHRINE
Injection, USP
1 mg/mL
Ampul
Protect from light until ready to use.
Rx only
Epinephrine Injection, USP 1 mg/mL is a sterile, nonpyrogenic
solution. Each mL contains epinephrine 1
mg; sodium chloride 9 mg; sodium metabisulfite 0.9 mg added. May
contain hydrochloric acid for pH
adjustment.
The solution contains no bacteriostat or antimicrobial agent. It is
administered by the following routes:
intravenous, intracardiac (left ventricular chamber), via endotracheal
tube into the bronchial tree,
subcutaneous or intramuscular.
Epinephrine, USP is a sympathomimetic (adrenergic) agent designated
chemically as 4-[1-hydroxy-2
(methylamino) ethyl]-1,2 benzenediol, a white, microcrystalline
powder. It has the following structural
formula:
Sodium Chloride, USP is chemically designated NaCl, a white,
crystalline compound freely soluble in
water.
The actions of epinephrine resemble the effects of stimulation of
adrenergic nerves. To a variable
degree it acts on both alpha and beta receptor sites of sympathetic
effector cells. Its most prominent
actions are on the beta receptors of the heart, vascular and other
smooth muscle. When given by rapid
intravenous injection, it produces a rapid rise in blood pressure,
mainly systolic, by (1) direct
stimulation of cardiac muscle which increases the strength of
ventricular contraction, (2) increasing the
heart rate and (3) constriction of the arterioles in the skin, mucosa
and splanchnic areas of the
circulation.
When given by slow intravenous injection epinephrine usually produces
only a moderate rise in systolic
and a fall in diastolic pressure. Although some increase in pulse
pressure occurs, there is usually no
great elevation in mean blood pressure. Accordingly, the compensatory
reflex mechanisms that come
into play with a pronounced increase in blood pressure do not
antagonize the direct cardiac actions of
epinephrine as much as with catecholamines that have a predominant
acti